Search Results | Diabetes Care | American Diabetes Association

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11

Nanette C. Schloot, Minh N. Pham, Mohammed I. Hawa, Paolo Pozzilli, Werner A. Scherbaum, Matthias Schott, Hubert Kolb, Steven Hunter, Guntram Schernthaner, Charles Thivolet, Jochen Seissler, Richard David Leslie, for the Action LADA Group

Diabetes Care 2016;39(11):1932–1939

DOI: https://doi.org/10.2337/dc16-0293

Published: 29 August 2016

View article

Includes: Supplementary data

Journal Articles

Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOS

Guntram Schernthaner, Avivit Cahn, Itamar Raz

Diabetes Care 2016;39(Supplement_2):S210–S218

DOI: https://doi.org/10.2337/dcS15-3009

Published: 16 July 2016

View article

Journal Articles

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial. Diabetes Care 2014;37: 1392–1400 . DOI: 10.2337/dc13-1391

Diabetes Care 2015;38(1):178

DOI: https://doi.org/10.2337/dc15-rt01

Published: 13 December 2014

View article

Journal Articles

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz

Diabetes Care 2014;37(11):e247

DOI: https://doi.org/10.2337/dc14-1790

Published: 10 October 2014

View article

Journal Articles

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy

Pascale Fouqueray, Valdis Pirags, Michaela Diamant, Guntram Schernthaner, Harold E. Lebovitz, Silvio E. Inzucchi, Clifford J. Bailey

Diabetes Care 2014;37(7):1924–1930

DOI: https://doi.org/10.2337/dc13-2349

Published: 12 June 2014

View article

Includes: Supplementary data

Journal Articles

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

Philip Home, Matthew Riddle, William T. Cefalu, Clifford J. Bailey, Reinhard G. Bretzel, Stefano del Prato, Derek Leroith, Guntram Schernthaner, Luc van Gaal, Itamar Raz

Diabetes Care 2014;37(6):1499–1508

DOI: https://doi.org/10.2337/dc13-2743

Published: 10 May 2014

View article

Journal Articles

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013;36: 908–913

Diabetes Care 2014;37(5):1494

DOI: https://doi.org/10.2337/dc14-er05

Published: 10 April 2014

View article

Journal Articles

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial

Diabetes Care 2014;37(5):1392–1400

DOI: https://doi.org/10.2337/dc13-1391

Published: 10 April 2014

View article

Includes: Supplementary data

Journal Articles

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Guntram Schernthaner, MD, Jorge L. Gross, MD, Julio Rosenstock, MD, Michael Guarisco, MD, Min Fu, MS, Jacqueline Yee, MS, Masato Kawaguchi, MD, William Canovatchel, MD, Gary Meininger, MD

Diabetes Care 2013;36(9):2508–2515

DOI: https://doi.org/10.2337/dc12-2491

Published: 13 August 2013

View article

Includes: Supplementary data

Journal Articles

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

Guntram Schernthaner, MD, Craig J. Currie, MD, Gerit-Holger Schernthaner, MD

Diabetes Care 2013;36(Supplement_2):S155–S161

DOI: https://doi.org/10.2337/dcS13-2031

Published: 17 July 2013

View article

Journal Articles

Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time

Thomas Hörtenhuber, MD, Birgit Rami-Mehar, MD, Miriam Satler, MS, Katrin Nagl, MD, Clemens Höbaus, MD, Florian Höllerl, MD, Renate Koppensteiner, MD, Guntram Schernthaner, MD, Edith Schober, MD, Gerit-Holger Schernthaner, MD

Diabetes Care 2013;36(6):1647–1653

DOI: https://doi.org/10.2337/dc12-1206

Published: 15 May 2013

View article

Includes: Supplementary data

Journal Articles

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

Diabetes Care 2013;36(4):908–913

DOI: https://doi.org/10.2337/dc12-0931

Published: 14 March 2013

View article

Includes: Supplementary data

Journal Articles

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Pascale Fouqueray, MD, Valdis Pirags, MD, Silvio E. Inzucchi, MD, Clifford J. Bailey, PHD, Guntram Schernthaner, MD, Michaela Diamant, MD, Harold E. Lebovitz, MD

Diabetes Care 2013;36(3):565–568

DOI: https://doi.org/10.2337/dc12-0453

Published: 13 February 2013

View article

Journal Articles

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010

Guntram Schernthaner, MD, Johanna M. Brix, MD, Hans-Peter Kopp, MD, Gerit Holger Schernthaner, MD

Diabetes Care 2011;34(Supplement_2):S355–S360

DOI: https://doi.org/10.2337/dc11-s253

Published: 22 April 2011

View article

Journal Articles

Hypoglycemia and Cardiovascular Risks

Brian M. Frier, MD, Guntram Schernthaner, MD, Simon R. Heller, MD

Diabetes Care 2011;34(Supplement_2):S132–S137

DOI: https://doi.org/10.2337/dc11-s220

Published: 22 April 2011

View article

Journal Articles

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

David Peter Lorant, MD, Milan Grujicic, MD, Clemens Hoebaus, MD, Johanna-Maria Brix, MD, Florian Hoellerl, MD, Guntram Schernthaner, MD, Renate Koppensteiner, MD, Gerit-Holger Schernthaner, MD

Diabetes Care 2011;34(1):156–161

DOI: https://doi.org/10.2337/dc10-0788

Published: 07 October 2010

View article

Journal Articles

Time to Insulin Initiation Cannot Be Used in Defining Latent Autoimmune Diabetes in Adults

Sinead Brophy, PHD, Knud Yderstræde, PHD, Didac Mauricio, PHD, Stephen Hunter, PHD, Mohammed Hawa, PHD, Paolo Pozzilli, PHD, Guntram Schernthaner, PHD, Nanette Schoot, PHD, Raffaella Buzzetti, PHD, Helen Davies, PHD, David Leslie, PHD, Rhys Williams, PHD, on behalf of the Action LADA Group

Diabetes Care 2008;31(3):439–441

DOI: https://doi.org/10.2337/dc07-1308

Published: 01 March 2008

View article

Includes: Supplementary data

Journal Articles

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Guntram Schernthaner, MD, John M. Morton, MD

Diabetes Care 2008;31(Supplement_2):S297–S302

DOI: https://doi.org/10.2337/dc08-s270

Published: 01 February 2008

View article

Journal Articles

Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes

Katarzyna Krzyzanowska, MD, Friedrich Mittermayer, MD, Michael Wolzt, MD, Guntram Schernthaner, MD

Diabetes Care 2007;30(7):1834–1839

DOI: https://doi.org/10.2337/dc07-0019

Published: 01 July 2007

View article

Journal Articles

Response to Iafusco et al.

Guntram Schernthaner, MD, Wolfgang Wein, MD

Diabetes Care 1998;21(10):1778

DOI: https://doi.org/10.2337/diacare.21.10.1778a

Published: 01 October 1998

View article

NARROW

Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11

Is the Use of DPP-4 Inhibitors Associated With an Increased Risk for Heart Failure? Lessons From EXAMINE, SAVOR-TIMI 53, and TECOS

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial. Diabetes Care 2014;37: 1392–1400 . DOI: 10.2337/dc13-1391

Response to Comment on Home et al. Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges? Diabetes Care 2014;37:1499–1508

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013;36: 908–913

Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

Endothelial Progenitor Cells Are Related to Glycemic Control in Children With Type 1 Diabetes Over Time

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010

Hypoglycemia and Cardiovascular Risks

Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease

Time to Insulin Initiation Cannot Be Used in Defining Latent Autoimmune Diabetes in Adults

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes

Response to Iafusco et al.

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only